BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue2,160,1532,068,1722,019,441
Cost of Revenue972,754930,085897,771
Gross Profit1,187,3991,138,0871,121,670
Operating Expenses
Research Development250,301205,864192,972
Selling General and Administrative808,942816,724761,990
Non Recurring11,50662,30562,305
Others---
Total Operating Expenses---
Operating Income or Loss116,65053,194166,708
Income from Continuing Operations
Total Other Income/Expenses Net3,06910,308831
Earnings Before Interest and Taxes119,71963,502167,539
Interest Expense21,91421,94221,692
Income Before Tax97,80541,560145,847
Income Tax Expense-24,44415,56036,608
Minority Interest---
Net Income From Continuing Ops122,24926,000109,239
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income122,24926,000109,239
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares122,24926,000109,239